Evfraxy 60 mg/ml

Evfraxy 60 mg/ml is a medicine authorised by Swissmedic under authorisation number 70140. The authorisation holder is Medius AG. The medicinal product code is Biotechnological medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 18 November 2025 and the authorisation is limited until 17 November 2030. ATC code M05BX04 places the medicine in the group Drugs for treatment of bone diseases.

  • Dispensing category B
  • Authorisation number 70140
  • ATC M05BX04
  • Biotechnological medicines
Authorisation data
Authorisation number70140
NameEvfraxy 60 mg/ml
Full nameEvfraxy 60 mg/ml, Injektionslösung in einer Fertigspritze
Authorisation holderMedius AG
Medicinal product codeBiotechnological medicines
Dispensing categoryB · Prescription only
ATC codeM05BX04
First authorisation18 November 2025
Authorisation validity17 November 2030
Strengths
No.NameDispensing categoryAuthorisation date
1Evfraxy 60 mg/ml, Injektionslösung in einer FertigspritzeB18 November 2025

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
11Fertigspritze(n)M05BX0407.99.0.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Evfraxy 60 mg/ml authorised in Switzerland?

Yes. Evfraxy 60 mg/ml is authorised by Swissmedic under authorisation number 70140, data as of 01 September 2026. The authorisation is limited until 17 November 2030.

Which dispensing category does Evfraxy 60 mg/ml have?

Evfraxy 60 mg/ml is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Evfraxy 60 mg/ml?

The authorisation holder is Medius AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com